Showing results (161-170 of 261) with videos related to
Sort By:
Pageof 27
Cancer Immunology, Immunotherapy : CII|April 16, 2023
Incidence of serious adverse events caused by tyrosine kinase inhibitor treatment following immune checkpoint inhibitor therapy in advanced NSCLC patients with oncogenic driver alterationsYukiko Shimoda, Tatsuya Yoshida, Jun Miyakoshi, et al.Cancers|November 11, 2022
Cancer Cachexia among Patients with Advanced Non-Small-Cell Lung Cancer on Immunotherapy: An Observational Study with Exploratory Gut Microbiota AnalysisTaiki Hakozaki, Alexis Nolin-Lapalme, Masato Kogawa, et al.Protein Science : a Publication of the Protein Society|November 17, 2010
Structures of the first and second double-stranded RNA-binding domains of human TAR RNA-binding proteinSeisuke Yamashita, Takashi Nagata, Masahito Kawazoe, et al.Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|June 29, 2022
Comparison of Mental Health among Japanese Healthcare Workers at Two Points during the COVID-19 PandemicNobuyasu Awano, Nene Oyama, Keiko Akiyama, et al.Respiratory Investigation|July 2, 2021
Side effects and antibody titer transition of the BNT162b2 messenger ribonucleic acid coronavirus disease 2019 vaccine in JapanTakehiro Izumo, Naoyuki Kuse, Nobuyasu Awano, et al.Japanese Journal of Clinical Oncology|January 28, 2021
Medical costs of Japanese lung cancer patients during end-of-life careNobuyasu Awano, Takehiro Izumo, Minoru Inomata, et al.FEBS Letters|September 27, 2012
Structural insight into the interaction of ADP-ribose with the PARP WWE domainsFahu He, Kengo Tsuda, Mari Takahashi, et al.Journal of Molecular Biology|August 18, 2009
Structural and functional characterization of the NHR1 domain of the Drosophila neuralized E3 ligase in the notch signaling pathwayFahu He, Kohei Saito, Naohiro Kobayashi, et al.Chembiochem : a European Journal of Chemical Biology|December 4, 2014
Controlling the fluorescence of benzofuran-modified uracil residues in oligonucleotides by triple-helix formationTakashi Kanamori, Hiroki Ohzeki, Yoshiaki Masaki, et al.Japanese Journal of Clinical Oncology|January 28, 2021
Medical costs of lung cancer care in Japan during the first one or two years after initial diagnosisNobuyasu Awano, Takehiro Izumo, Minoru Inomata, et al.Pageof 27